CLINICAL COURSE AND THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND CHEMOTHERAPY
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference230 articles.
1. Interferon alpha-2b as therapy for Ph′-positive chronic myelogenous leukemia: A study of 82 patients treated with intermittent or daily administration;Alimena;Blood,1988
2. UK Medical Research Council randomized multicenter trial of interferon-αn1 for chronic myeloid leukemia: Improved survival irrespective of cytogenetic response;Allan;Lancet,1995
3. A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia;Anger;Blut,1989
4. Graft-versus-leukemia: No longer an epiphenomenon;Antin;Blood,1993
5. Bone marrow transplantation for chronic myeloid leukaemia in chronic phase: Importance of graft-versus-leukaemia effect;Apperley;Br J Haematol,1988
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Integrated computational biology analysis to evaluate target genes for chronic myelogenous leukemia;Molecular Medicine Reports;2018-06-05
2. First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI;Leukemia & Lymphoma;2017-10-03
3. Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib;Biologics: Targets and Therapy;2016-02
4. A Study of Haemostatic Parameters in Patients of Chronic Myeloid Leukaemia;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2016
5. Follow-up of the tumor load in patients with de novo chronic myeloid leukemia and in complete cytogenetic remission treated with imatinib in Colombia;Colombia Medica;2012-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3